# Pliant Therapeutics, Inc. (PLRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/PLRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -20.04M | $ -19.23M | $ 28.78M | $ 165.17M |
| 2025 | $ 0 | $ -152.92M | $ -131.79M | $ 29.11M | $ 181.21M |
| 2024 | $ 0 | $ -221.05M | $ -167.49M | $ 60.19M | $ 304.08M |
| 2023 | $ 1.71M | $ -174.45M | $ -126.81M | $ 11.37M | $ 473.58M |
| 2022 | $ 10.82M | $ -137.76M | $ -107.68M | $ 15.82M | $ 313.34M |
| 2021 | $ 9.00M | $ -115.61M | $ -92.00M | $ 7.19M | $ 199.06M |
| 2020 | $ 53.27M | $ -52.91M | $ -49.43M | $ 0 | $ 283.06M |
| 2019 | $ 73.64M | $ -3.59M | $ -4.79M | $ 444.0K | $ -435.0K |
| 2018 | $ 0 | $ -9.38M | $ -11.20M | $ 0 | $ 3.35M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.17 |
| Liabilities / Eq | 0.23 |
| Current Ratio | 16.89 |

## Other views

- [Metrics](https://sponda.capital/en/PLRX.md)
- [Charts](https://sponda.capital/en/PLRX/charts.md)
- [Compare](https://sponda.capital/en/PLRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-13.